Intravenous Solutions Market Research Report by Type (Peripheral Parenteral Nutrition and Total Parenteral Nutrition), by Nutrients (Carbohydrates, Parenteral Lipid Emulsion, and Single Dose Amino Acid Solution), by State (California, Florida, and Illinois) - United States Forecast to 2026 - Cumulative Impact of COVID-19
The United States Intravenous Solutions Market size was estimated at USD 2,066.93 million in 2020 and expected to reach USD 2,364.60 million in 2021, at a CAGR 11.62% to reach USD 3,998.74 million by 2026.
Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage: This research report categorizes the Intravenous Solutions to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Peripheral Parenteral Nutrition and Total Parenteral Nutrition.
Based on Nutrients, the market was studied across Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, and Vitamins & Minerals.
Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.
Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Intravenous Solutions Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario: The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Intravenous Solutions Market, including Ajinomoto Co., Inc., Anhui Medipharm Co. Ltd, Axa Parenterals Ltd, B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, Bottar Law, PLLC, Fresenius Kabi AB, Grifols SA, Honeywell International Inc., ICU Medical Inc., JW Life Science Corporation\, MediaLab, Inc., Nymak Pharma Ltd, Otsuka Pharmaceutical Co., Ltd., Salius Pharma Private Limited, Sichuan Kelun Pharmaceutical Co., Ltd., Terumo Corporation, Varni Corporation, and Vifor Pharma AG.
The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as: 1. What is the market size and forecast of the United States Intravenous Solutions Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the United States Intravenous Solutions Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Intravenous Solutions Market? 4. What is the competitive strategic window for opportunities in the United States Intravenous Solutions Market? 5. What are the technology trends and regulatory frameworks in the United States Intravenous Solutions Market? 6. What is the market share of the leading vendors in the United States Intravenous Solutions Market? 7. What modes and strategic moves are considered suitable for entering the United States Intravenous Solutions Market?
Our reports have been used by over 10K customers, including:
The global pharmaceutical drug delivery market is projected to reach USD 2,206.5 billion by 2026 from USD 1,656.9 billion in 2021, at a CAGR of 5.9% during the forecast period. Growth in the pharmaceutical drug delivery market can largely be attributed to factors such as the rising prevalence of chronic diseases, growing biologics market,...
411 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Nov 2021
Toxicology is the study of adverse effects that occur in living organisms and its environment due to chemicals, physical or biological substances at ambient exposure levels. Toxicology testing regulations are already in place for most of the developed countries across industries such as chemicals, pesticides, consumer...
The aptamers market valued at an estimated USD 151 million in 2021 and is projected to reach USD 342 million by 2026, at a CAGR of 17.7% during the forecast period. Growth of aptamers market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages...
Forecasts by Product Type (Rotary Atomizer SD, Nozzle Atomizer SD, Fluidized SD, Centrifugal SD, Others), by Cycle Type (Closed Loop, Open Loop), by Stage Type (Single Stage, Two Stage, Multi Stage), by Flow Type (Co Current, Counter Current, Mixed) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies...
The global pharmaceutical contract development and manufacturing market is projected to reach USD 171.3 billion by 2026 from USD 120.6 billion in 2021, at a CAGR of 7.3% during the forecast period. Market growth is driven mainly by factors such as rising demand for generics, increasing investments in pharmaceutical R&D, and investments in...
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries....
The healthcare analytical testing services market is projected to reach USD 9.8 billion by 2026 from USD 5.6 billion in 2021, at a CAGR of 11.9%. Growth in the market is driven by the rising trend of outsourcing of analytical testing by pharmaceutical companies and medical device companies, an increasing number of clinical trials, and the...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the precision medicine market are Qiagen, Novartis AG, Medtronic, AstraZeneca plc., Quest Diagnostics, Thermo Fisher Scientific Inc., Pfizer, Bristol-Myers Squibb, Merck & Co. Inc., Tepnel Pharma Services, Abbott Laboratories, Takeda Pharmaceutical Company Ltd., and Eli Lilly and Company. The global precision medicine...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the sample preparation market are Agilent Technologies, Bio-Rad Laboratories, Danaher Corporation, Illumina, Qiagen NV, PerkinElmer, F Hoffman La Roche, Tecan Group Ltd., Hamilton Company, Norgen Biotek Corporation, Waters Corporation, Promega Corporation, and Biotage AB. The global sample preparation market is expected...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.